EARLY BREAST CANCER

This study is testing whether adding the drug ribociclib to standard hormone therapy helps prevent breast cancer from returning after surgery. The trial will enroll 1,400 adults with early-stage, hormone-positive breast cancer who have already had surgery. Participants will take …

This study tests whether MRI scans can identify patients with aggressive triple-negative breast cancer who can safely skip the harshest part of chemotherapy. All participants receive initial treatment with four drugs. Those whose MRI shows no remaining cancer after this phase ski…

This study is testing if following a Mediterranean diet during chemotherapy can help early breast cancer patients. Researchers want to see if the diet improves gut bacteria, quality of life, and treatment outcomes. They are especially interested in whether these benefits are stro…

This study is testing whether a handheld robotic device called HandX can help surgeons safely perform a type of mastectomy that uses a small side incision. The goal is to remove breast tissue while preserving the nipple and skin, aiming for less scarring and better cosmetic resul…

This study is testing whether a digital health program can help people feel better during chemotherapy. It uses a smartphone app for patients to track symptoms and connects them with nurses for support. The goal is to see if this approach improves quality of life and helps patien…

This study aims to understand how consistently patients take their breast cancer medications. Researchers will compare two groups: those taking a standard hormone therapy pill versus those taking that pill plus an additional drug called abemaciclib. They will track 319 patients f…

This study aims to create a detailed atlas of proteins and cell structures within different types of breast cancer. Researchers will analyze tumor samples from 1,050 patients with early-stage or newly diagnosed metastatic breast cancer. The goal is to understand how fat storage a…